Celebrex and Vitiligo - a phase IV clinical study of FDA data

Summary:

Vitiligo is reported as a side effect among people who take Celebrex (celecoxib), especially for people who are male, 50-59 old, have been taking the drug for 5 - 10 years also take Mobic, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Vitiligo when taking Celebrex. It is created by eHealthMe based on reports of 147,540 people who have side effects when taking Celebrex from the FDA, and is updated regularly.

What is Celebrex?

Celebrex has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 151,105 Celebrex users. Check the latest studies of Celebrex.

What is Vitiligo?

Vitiligo (pigment is lost from areas of the skin) is found to be associated with 168 drugs and 305 conditions by eHealthMe. Check the latest studies of Vitiligo.

On Jul, 11, 2026

147,540 people reported to have side effects when taking Celebrex.
Among them, 18 people (0.01%) have Vitiligo.

Among these 18 people:

How long have people been on Celebrex when they have Vitiligo? *

What is the gender of people who have Vitiligo when taking Celebrex? *

female: 38.89 %
male: 61.11 %

What is the age of people who have Vitiligo when taking Celebrex? *

What are other drugs people take besides Celebrex? *

What are other side effects people have besides Vitiligo? *

Rashes (redness): 8 people, 44.44%
Fatigue (feeling of tiredness): 7 people, 38.89%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 38.89%
Localised Infection (infection at the single location): 5 people, 27.78%
Hypoaesthesia (reduced sense of touch or sensation): 5 people, 27.78%
Joint Pain: 5 people, 27.78%
Infection: 4 people, 22.22%
Hyperhidrosis (abnormally increased sweating): 4 people, 22.22%
Histiocytic Necrotising Lymphadenitis (swollen glands"" in the neck): 4 people, 22.22%
Emotional Distress: 4 people, 22.22%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 33.33%
High Blood Pressure: 4 people, 22.22%
Fluid Retention (an abnormal accumulation of fluid in the blood): 4 people, 22.22%
Stress And Anxiety: 3 people, 16.67%
Migraine (headache): 3 people, 16.67%
Arrhythmias (irregular heartbeat): 3 people, 16.67%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 11.11%
Upper Respiratory Tract Infection: 1 person, 5.56%
Trigger Finger: 1 person, 5.56%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Celebrex and have Vitiligo?

- Check whether Vitiligo is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Celebrex:

Celebrex (151,105 reports)

Vitiligo treatments and more:

Vitiligo (3,513 reports)

Browse all side effects of Celebrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vitiligo:

Vitiligo (168 drugs)

Browse all the conditions that are associated with Vitiligo:

Vitiligo (305 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on celecoxib (the active ingredients of Celebrex) and Celebrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.